News & Events

Learn more about TriNetX through media coverage and upcoming events

Contact Public Relations

News & Events

Learn more about TriNetX through media coverage and upcoming events

Contact Public Relations

Press Releases

TriNetX Appoints New Members to Board of Directors

Ian Read, former Pfizer CEO & Chairman, named board chairman

TriNetX Expands the Breadth and Depth of its Global Research Network and Real-World Data Set Adding COVID-19 Vaccination Data to Longitudinal Patient Histories

TriNetX today announced that COVID-19 vaccination data is now available within the TriNetX platform and real-world data (RWD) set for clinical and observational research.

VUD Names TriNetX as Its Recommended Research Platform

Partnership to Accelerate Clinical Research Innovation Across German Association of 34 University Hospitals

View all >>

Blog

Real-World Data and Artificial Intelligence: Solving Key Clinical Trial Challenges

May 8, 2025

Courtesy of TriNetX ExpertsBringing a new drug to market is expensive, complex, and slow. Clinical trials are a major bottleneck. $314 million - $4.46 billion: Estimated cost for a new drug1 Up to...

« Older Entries

Next Entries »

Recent Scientific Publications

View all

Harrison, S. Fazio-Eynullayeva, E., Lane, D., Underhill, P., Lip, G. “Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19.” Published in Journal of Arrhythmia, 11 December 2020.

Learn more

View all >>

Applebaum, L., Berg, A., Cambronero, J., Dang, T., Jin, C., Zhang, L., Palchuk, M., Kundrot, S., Evans, L., Kaplan, I., Rinard, M. “Development of a pancreatic cancer prediction model using a multinational medical records database.” Journal of Clinical Oncology 2021 39:3_suppl, 394-394. 22 January 2021.

Learn more

Pakhchanian, H., Raiker, R., Mukherjee, A., Khan, A., Singh, S., Chatterjee, A. “Outcomes of COVID-19 in CKD Patients.”. CJASN Feb 2021, CJN.13820820; DOI: 10.2215/CJN.13820820. February 2021.

Learn more